ALISSA ROBINSON: Open Payments
NPI 1740799907 · TAUNTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$628 in 22 payments from 5 companies in 2025. Trend: 2023 $113 · 2024 $482 · 2025 $628
Food & beverage: $628
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 4 | $209 |
| Regeneron Healthcare Solutions, Inc. | 8 | $160 |
| GlaxoSmithKline, LLC. | 6 | $158 |
| Lilly USA, LLC | 2 | $50 |
| Amgen Inc. | 2 | $50 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, ZEPBOUND, MOUNJARO.
Industry payments across MA — which companies pay providers there.
